Profile data is unavailable for this security.
About the company
Biome Australia Limited is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, Biome Her Probiotic, among others.
- Revenue in AUD (TTM)21.95m
- Net income in AUD957.91k
- Incorporated2018
- Employees30.00
- LocationBiome Australia Ltd192-194 Johnston Street, CollingwoodMELBOURNE 3066AustraliaAUS
- Phone+61 39017-5800
- Websitehttps://biomeaustralia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitura Health Ltd | 124.04m | 3.28m | 27.84m | 119.00 | 7.78 | 0.577 | 5.25 | 0.2244 | 0.0054 | 0.0054 | 0.2034 | 0.0728 | 1.69 | 16.43 | 10.46 | -- | 4.11 | 12.75 | 5.72 | 17.62 | 27.21 | 30.97 | 2.43 | 6.06 | 1.05 | 9.50 | 0.2009 | -- | 0.1341 | 298.23 | -5.35 | -- | 129.38 | -- |
| TrivarX Ltd | 1.13m | -943.23k | 28.84m | 4.00 | -- | 1.22 | -- | 25.46 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
| Little Green Pharma Ltd | 38.49m | 5.86m | 33.64m | -- | 5.68 | 0.3909 | 3.47 | 0.874 | 0.0194 | 0.0194 | 0.1268 | 0.2814 | 0.4262 | 0.8199 | 14.01 | -- | 6.48 | -- | 7.09 | -- | 67.46 | -- | 15.21 | -- | 0.8728 | -4.71 | 0.0541 | -- | 43.67 | -- | 140.77 | -- | -- | -- |
| Avecho Biotechnology Ltd | 1.38m | -3.62m | 36.73m | 29.00 | -- | 38.46 | -- | 26.61 | -0.0011 | -0.0011 | 0.0004 | 0.0003 | 0.2115 | 4.46 | 1.91 | -- | -55.49 | -61.23 | -72.92 | -73.27 | 62.27 | 55.45 | -262.41 | -382.04 | 4.53 | -8.03 | 0.0647 | -- | 139.19 | -23.20 | 9.15 | -- | -- | -- |
| Inoviq Ltd | 916.53k | -7.24m | 46.46m | 85.00 | -- | 2.09 | -- | 50.69 | -0.0615 | -0.0615 | 0.0078 | 0.1581 | 0.0401 | 3.61 | 0.9209 | -- | -31.68 | -43.01 | -34.39 | -45.87 | 86.76 | 89.08 | -789.61 | -1,543.44 | 7.54 | -- | 0.012 | -- | 21.17 | 57.69 | -5.77 | -- | -- | -- |
| Medical Developments International Ltd | 40.64m | -436.00k | 49.57m | 68.00 | -- | 0.9051 | 19.55 | 1.22 | -0.0039 | -0.0039 | 0.3608 | 0.4862 | 0.6306 | 1.30 | 5.32 | -- | -0.6765 | -16.68 | -0.7455 | -18.92 | 75.19 | 72.70 | -1.07 | -47.08 | 4.54 | -- | 0.0324 | -- | 17.82 | 11.30 | 100.23 | -24.33 | -34.91 | -- |
| Neurizon Therapeutics Ltd | 126.01k | -14.85m | 62.88m | 52.00 | -- | 5.82 | -- | 498.98 | -0.0293 | -0.0293 | 0.0003 | 0.0155 | 0.0082 | -- | 3.87 | -- | -96.23 | -65.69 | -146.99 | -74.86 | -- | -- | -11,785.73 | -368.00 | -- | -201.18 | 0.1636 | -- | -- | -- | -86.45 | -- | -44.79 | -- |
| Radiopharm Theranostics Ltd | 3.63m | -38.34m | 74.43m | 14.00 | -- | 1.11 | -- | 20.48 | -0.0179 | -0.0179 | 0.0017 | 0.0189 | 0.0458 | -- | 0.6382 | 259,530.70 | -48.38 | -- | -59.58 | -- | 1.08 | -- | -1,055.27 | -- | -- | -7.52 | 0.00 | -- | 1,114.26 | -- | 20.04 | -- | -- | -- |
| Biome Australia Ltd | 21.95m | 957.91k | 90.16m | 30.00 | 96.43 | 14.88 | 73.50 | 4.11 | 0.0042 | 0.0042 | 0.0985 | 0.0272 | 1.93 | 2.43 | 6.05 | -- | 8.42 | -43.09 | 16.62 | -74.65 | 61.17 | 60.15 | 4.36 | -31.84 | 1.29 | 4.57 | 0.2863 | -- | 41.57 | 80.17 | 112.85 | -- | 2.18 | -- |
| Botanix Pharmaceuticals Ltd | 5.76m | -86.40m | 117.56m | 1.00 | -- | 1.28 | -- | 20.42 | -0.0466 | -0.0466 | 0.0031 | 0.0415 | 0.0477 | 0.2477 | 3.48 | -- | -71.53 | -50.27 | -81.16 | -56.02 | 36.99 | -- | -1,500.65 | -1,888.17 | 2.87 | -- | 0.2226 | -- | 856.64 | 102.14 | -522.91 | -- | 63.43 | -- |
| Vita Life Sciences Ltd | 93.27m | 10.44m | 146.93m | 124.00 | 14.67 | 2.65 | -- | 1.58 | 0.1833 | 0.1833 | 1.64 | 1.01 | 1.21 | 2.29 | 7.28 | -- | 13.52 | 15.15 | 18.79 | 21.21 | 61.15 | 59.76 | 11.18 | 11.85 | 2.10 | -- | 0.0409 | 57.39 | 17.31 | 14.95 | 18.80 | 11.36 | 44.98 | 26.93 |
| Recce Pharmaceuticals Ltd | 7.70m | -21.43m | 150.38m | -- | -- | -- | -- | 19.52 | -0.0899 | -0.0899 | 0.0325 | -0.0106 | 0.8203 | -- | 25.91 | -- | -228.15 | -150.15 | -- | -318.01 | -- | -- | -278.12 | -340.57 | -- | -17.98 | 1.49 | -- | 47.14 | 46.35 | -21.33 | -- | 34.71 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Netwealth Investments Ltd.as of 28 Sep 2025 | 2.06m | 0.92% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 483.20k | 0.22% |
| Mandarine Gestion SAas of 30 Jun 2025 | 240.00k | 0.11% |
